CLOSE X

My Gullak

छोटी बचत, बड़ी कमाई

FUND CARD

MORE FROM MUTUAL FUNDS

DSP Healthcare Fund-Reg(G)

As on Jan-21-2025 change fund
40.61  up-0.01 (-0.01%)

fund objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 17-Jan-2025)19.1621.8820.9132.7640.62
Net Assets(Rs Crores) (as on 17-Jan-2025) 1109.58 1291.46 1202.10 2352.32 3339.79
Scheme Returns(%)(Absolute)79.3413.12-4.6056.8623.16
B'mark Returns(%)(Absolute)NANANANANA
Category Rank26/7544/7561/7620/909/98
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2024-20251.8822.291.97NA
2023-202414.709.6012.5510.74
2022-2023-11.909.134.21-4.59
2021-202213.207.501.95-7.96
2020-202126.1728.859.65-0.61
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...10.59 
Suven Pharmaceuticals Ltd.8.49 
Cipla Ltd.8.20 
Ipca Laboratories Ltd.8.14 
Globus Medical Inc5.70 
Illumina Inc.4.78 
Alembic Pharmaceuticals Ltd.4.54 
Gland Pharma Ltd.4.38 
Apollo Hospitals Enterprise Ltd.4.07 
Concord Biotech Ltd.3.87 

Category

Sector Funds

Launch Date

30-Nov-18

Scheme Benchmark

BSE HEALTH CARE - TRI

AUM ( in Cr.)

3,339.79

portfolio price to book value

7.8

investing style?

Mid Growth

fund manager?

Chirag Dagli

inception date (regular plan)

30-Nov-18

expense ratio (regular plan) %

1.90

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs69.65
Hospital & Healthcare Services11.99
Insurance1.29

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-20183,339.7932.6322.3628.35NA25.60
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20185,320.2934.3423.9028.58NA22.62
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19993,628.0330.1023.1327.5813.0416.46
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-20151,287.4527.2320.4925.50NA12.78
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-20051,235.9130.8320.1225.6512.1218.57
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20048,914.8921.3519.2325.7714.3020.79
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021230.7927.6018.15NANA16.41
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019890.3321.8017.7322.25NA22.01
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,863.5226.9517.6426.57NA22.13
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201986.2631.7917.0921.63NA19.72
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-20231,577.1237.34NANANA44.18
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023439.0227.56NANANA29.68
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023424.0415.00NANANA30.82
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024282.62NANANANA29.81
Bajaj Finserv Healthcare Fund-Reg(G)Large-Growth 27-Dec-2024292.24NANANANA-3.87
PGIM India Healthcare Fund-Reg(G)Large-Growth 06-Dec-2024109.73NANANANA-3.70
Bandhan BSE Healthcare Index Fund-Reg(G)Large-Growth 06-Sep-202418.32NANANANA-2.43
CORPORATE ADDRESS MY GULLAK1206, Vijaya Building Barakhamba Road New Delhi -110001
Call Us 9876543210-15
Email Us mygullak@mygullak.net
USEFUL LINKS
PlayStore
DISCLAIMER

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs. ARN - 250088

Copyright 2025 © My Gullak All Right Reserved

Designed , Developed & Content Powered by   Accord Fintech Pvt. Ltd.